Institute: India to Have 1 Million COVID Deaths by Aug.
CHENNAI (Reuters) --India on Saturday reported its highest ever single-day COVID-19 death toll, as cases continued to rise and states imposed stricter lockdowns.
India’s health ministry reported 4,187 fatalities over the past 24 hours, taking the overall death toll close to 240,000. The Institute for Health Metrics and Evaluation estimates that India will see 1 million COVID deaths by August.
Cases rose by 401,078 on Saturday, bringing the total since the start of the pandemic to 21.9 million.
Medical experts say the real numbers of COVID-19 cases and fatalities are likely to be far higher than official tallies.
Tamil Nadu, known for its automobile manufacturing including BMW, Daimler, Hyundai, Ford, Nissan and Renault, said it would move from a partial to a full lockdown on Monday, shutting public transport and state-run alcohol retailers.
Neighboring Karnataka state extended a total shutdown late on Friday. The state capital Bengaluru is a major tech hub, home to major offices of companies including Google, Amazon and Cisco.
India is yet to impose a national lockdown as it did during its first wave last year, but around half of all its states have imposed a total shutdown. The rest are under a partial shutdown.
India’s drug regulator on Friday approved for emergency use a new drug called 2-deoxy-D-glucose after clinical trials showed it aided the recovery of hospitalized patients and reduced dependence on supplemental oxygen.
The drug was jointly developed by India’s state-run Defense Research and Development Organization and Hyderabad-based Dr. Reddy’s Laboratories Ltd.
Though it is the world’s biggest vaccine maker, India is struggling to produce and distribute enough doses to stem the wave of COVID-19.
The country has administered over 167 million vaccine doses but its rate of inoculation has fallen in recent days and only around 2% of its 1.4 billion people have received the two doses needed to be fully immunized.
While cases in the country’s northern and western areas have borne the brunt of the pandemic, southern states including Karnataka and Tamil Nadu have seen infections surge.
The second wave of the coronavirus pandemic in India has brought the healthcare system to the brink of collapse, with patients dying due to lack of oxygen or access to hospital beds.
Prime Minister Narendra Modi has been criticized for his handling of the oxygen shortage, though the government says it is doing all it can.
Medical journal Lancet said in an editorial on Saturday Prime Minister Modi’s attempts to stifle criticism were "inexcusable.”
"India must now restructure its response while the crisis rages. The success of that effort will depend on .. implementing a public health response that has science at its heart.”
India’s health ministry reported 4,187 fatalities over the past 24 hours, taking the overall death toll close to 240,000. The Institute for Health Metrics and Evaluation estimates that India will see 1 million COVID deaths by August.
Cases rose by 401,078 on Saturday, bringing the total since the start of the pandemic to 21.9 million.
Medical experts say the real numbers of COVID-19 cases and fatalities are likely to be far higher than official tallies.
Tamil Nadu, known for its automobile manufacturing including BMW, Daimler, Hyundai, Ford, Nissan and Renault, said it would move from a partial to a full lockdown on Monday, shutting public transport and state-run alcohol retailers.
Neighboring Karnataka state extended a total shutdown late on Friday. The state capital Bengaluru is a major tech hub, home to major offices of companies including Google, Amazon and Cisco.
India is yet to impose a national lockdown as it did during its first wave last year, but around half of all its states have imposed a total shutdown. The rest are under a partial shutdown.
India’s drug regulator on Friday approved for emergency use a new drug called 2-deoxy-D-glucose after clinical trials showed it aided the recovery of hospitalized patients and reduced dependence on supplemental oxygen.
The drug was jointly developed by India’s state-run Defense Research and Development Organization and Hyderabad-based Dr. Reddy’s Laboratories Ltd.
Though it is the world’s biggest vaccine maker, India is struggling to produce and distribute enough doses to stem the wave of COVID-19.
The country has administered over 167 million vaccine doses but its rate of inoculation has fallen in recent days and only around 2% of its 1.4 billion people have received the two doses needed to be fully immunized.
While cases in the country’s northern and western areas have borne the brunt of the pandemic, southern states including Karnataka and Tamil Nadu have seen infections surge.
The second wave of the coronavirus pandemic in India has brought the healthcare system to the brink of collapse, with patients dying due to lack of oxygen or access to hospital beds.
Prime Minister Narendra Modi has been criticized for his handling of the oxygen shortage, though the government says it is doing all it can.
Medical journal Lancet said in an editorial on Saturday Prime Minister Modi’s attempts to stifle criticism were "inexcusable.”
"India must now restructure its response while the crisis rages. The success of that effort will depend on .. implementing a public health response that has science at its heart.”